Ed Reznik

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

65h-index46.7kcitations291works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(109), Cancer Genomics and Diagnostics(98), Renal and related cancers(64), Microbial Metabolic Engineering and Bioproduction(33), Ferroptosis and cancer prognosis(32)

Publications269 total

Genomic landscape and clinical outcomes of MDM2 amplifications in biliary tract cancers.
Journal of Clinical Oncology·2026
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma
Cancers·2025Open Access
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Nature Communications·2025· 1 citedOpen Access
Functionally dominant hotspot mutations of mitochondrial ribosomal RNA genes in cancer
Nature Genetics·2025· 3 citedOpen Access
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma
European Urology·2025
Clonal Hematopoiesis and AKI in Estrogen-Dependent Cancers
Journal of the American Society of Nephrology·2025
A health-system-scale, episode-resolved multimodal atlas of cancer cachexia
2025· 1 citedOpen Access
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone
Urologic Oncology Seminars and Original Investigations·2025Open Access
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma
European Urology·2025· 2 citedOpen Access
Biomarkers for renal cell carcinoma — a pragmatic approach
Nature Reviews Urology·2025
Abstract 1526: An impaired ability to engage in oxidative phosphorylation as a unifying feature of renal carcinogenesis
Cancer Research·2025
UnitedMet harnesses RNA–metabolite covariation to impute metabolite levels in clinical samples
Nature Cancer·2025· 2 citedOpen Access
IP16-02 CLONAL HEMATOPOIESIS IS ASSOCIATED WITH HIGHER RISK OF ACUTE KIDNEY INJURY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
The Journal of Urology·2025
IP16-37 CLINICAL AND GENOMIC CHARACTERIZATION OF RENAL ONCOCYTOSIS
The Journal of Urology·2025
MP28-05 MLH1 MISMATCH REPAIR PREDICTS EXCEPTIONAL RESPONDER PHENOTYPES IN CLEAR-CELL RENAL CELL CARCINOMA
The Journal of Urology·2025
MP28-11 GENOMIC PATTERNS OF METASTATIC EVOLUTION UNDERLYING CLINICAL COURSE OF METASTATIC CLEAR CELL RENAL CELL CARCINOMA
The Journal of Urology·2025
Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk Cases
Urology Practice·2025· 4 cited
Engineering mtDNA deletions by reconstituting end joining in human mitochondria
Cell·2025· 15 cited
Abstract A020: Clonal hematopoiesis is associated with acute kidney injury in the context of breast, endometrial, and ovarian cancers
Cancer Research·2025
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
Cell·2024· 15 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Chris Sander(22), Nikolaus Schultz(19), Rehan Akbani(17), Walid K. Chatila(17), Konnor La(16), Vésteinn Thórsson(15), John A. Demchok(15), Ina Felau(15), Martin L. Ferguson(15), Sudha Chudamani(15), Juok Cho(15), Timothy Defreitas(15), Scott Frazer(15), Gad Getz(15), Apurva M. Hegde(15), Rupa S. Kanchi(15), Joshua Armenia(15), Debyani Chakravarty(15), Ritika Kundra(15), Augustin Luna(15)